Belite Bio, Inc. (BLTE)
174.02
-9.14
(-4.99%)
USD |
NASDAQ |
Sep 10, 14:58
Belite Bio Net Income (Quarterly) : -28.41M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.41M |
| March 31, 2026 | -26.94M |
| December 31, 2025 | -25.32M |
| September 30, 2025 | -21.69M |
| June 30, 2025 | -16.32M |
| March 31, 2025 | -14.28M |
| December 31, 2024 | -10.10M |
| Date | Value |
|---|---|
| September 30, 2024 | -8.679M |
| June 30, 2024 | -9.494M |
| March 31, 2024 | -7.871M |
| December 31, 2023 | -6.991M |
| September 30, 2023 | -10.94M |
| June 30, 2023 | -6.812M |
| March 31, 2023 | -6.895M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -8.603M |
| CorMedix, Inc. | 25.99M |
| Eloxx Pharmaceuticals, Inc. | -4.502M |
| Cannabis Global, Inc. | -0.062M |
| Breakthrough Chemistry, Inc. | -1.083M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 28.41M |
| EPS Diluted (Quarterly) | -0.7071 |
| Enterprise Value | 7.096B |
| Earnings Yield | -1.57% |
| Normalized Earnings Yield | -1.572 |